| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.882 | 0.003 | 0.882 | Caspase 3 stimulant | 0.83 0.004 CID_154699870 | ||
| 0.848 | 0.011 | 0.848 | Apoptosis agonist | 0.841 0.012 CID_154699870 | ||
| 0.793 | 0.002 | 0.892 | Melanin inhibitor | 0.892 0.001 CID_154699870 | CID_154699870 | |
| 0.761 | 0.016 | 0.761 | Caspase 9 stimulant | 0.716 0.022 CID_154699870 | ||
| 0.67 | 0.024 | 0.878 | Transcription factor NF kappa B inhibitor | 0.878 0.008 CID_154699870 | CID_154699870 | |
| 0.646 | 0.008 | 0.755 | Antioxidant | 0.755 0.005 CID_154699870 | CID_154699870 | |
| 0.606 | 0.005 | 0.606 | Topoisomerase II inhibitor | 0.581 0.005 CID_154699870 | ||
| 0.542 | 0.013 | 0.631 | Nitric oxide antagonist | 0.631 0.008 CID_154699870 | CID_154699870 | |
| 0.527 | 0.01 | 0.527 | Antimitotic | 0.368 0.029 CID_154699870 | ||
| 0.518 | 0.023 | 0.622 | Histamine release inhibitor | 0.622 0.008 CID_154699870 | CID_154699870 | |
| 0.515 | 0.037 | 0.515 | 15-Lipoxygenase inhibitor | |||
| 0.495 | 0.028 | 0.495 | 5 Hydroxytryptamine release stimulant | 0.268 0.081 CID_154699870 | ||
| 0.481 | 0.018 | 0.614 | Free radical scavenger | 0.614 0.008 CID_154699870 | CID_154699870 | |
| 0.448 | 0.006 | 0.448 | Protein-tyrosine phosphatase inhibitor | 0.351 0.012 CID_154699870 | ||
| 0.436 | 0.004 | 0.436 | Estrogen agonist | 0.227 0.007 CID_154699870 | ||
| 0.432 | 0.004 | 0.432 | Estrogen receptor beta antagonist | 0.116 0.037 CID_154699870 | ||
| 0.438 | 0.01 | 0.609 | Hepatoprotectant | 0.609 0.004 CID_154699870 | CID_154699870 | |
| 0.431 | 0.005 | 0.431 | Topoisomerase I inhibitor | 0.43 0.005 CID_154699870 | ||
| 0.429 | 0.005 | 0.429 | Protein-tyrosine phosphatase 1B inhibitor | 0.351 0.008 CID_154699870 | ||
| 0.409 | 0.004 | 0.409 | Estrogen antagonist | 0.148 0.024 CID_154699870 | ||
| 0.399 | 0.003 | 0.399 | Estrogen receptor beta agonist | 0.178 0.005 CID_154699870 | ||
| 0.404 | 0.011 | 0.404 | MAO inhibitor | |||
| 0.42 | 0.034 | 0.42 | 12-Lipoxygenase inhibitor | |||
| 0.411 | 0.027 | 0.438 | Hypoxia-inducible factor 1 alpha inhibitor | 0.438 0.022 CID_154699870 | CID_154699870 | |
| 0.388 | 0.005 | 0.388 | Alpha 2 adrenoreceptor antagonist | |||
| 0.466 | 0.103 | 0.766 | Antiinflammatory | 0.766 0.02 CID_154699870 | CID_154699870 | |
| 0.367 | 0.005 | 0.367 | Topoisomerase II alpha inhibitor | 0.351 0.005 CID_154699870 | ||
| 0.364 | 0.005 | 0.364 | Alpha 2c adrenoreceptor antagonist | |||
| 0.386 | 0.03 | 0.669 | Hypoglycemic | 0.669 0.005 CID_154699870 | CID_154699870 | |
| 0.356 | 0.012 | 0.662 | Amylase inhibitor | 0.662 0.003 CID_154699870 | CID_154699870 | |
| 0.372 | 0.035 | 0.398 | DNA damaging | 0.398 0.029 CID_154699870 | CID_154699870 | |
| 0.436 | 0.1 | 0.689 | Alpha-glucosidase inhibitor | 0.689 0.036 CID_154699870 | CID_154699870 | |
| 0.376 | 0.044 | 0.55 | Vasodilator, coronary | 0.55 0.01 CID_154699870 | CID_154699870 | |
| 0.375 | 0.046 | 0.464 | Spasmolytic | 0.464 0.028 CID_154699870 | CID_154699870 | |
| 0.338 | 0.01 | 0.338 | MAO B inhibitor | |||
| 0.403 | 0.076 | 0.68 | Antibacterial | 0.68 0.01 CID_154699870 | CID_154699870 | |
| 0.334 | 0.011 | 0.337 | Neurotrophic factor enhancer | 0.337 0.011 CID_154699870 | CID_154699870 | |
| 0.366 | 0.049 | 0.523 | Apoptosis antagonist | 0.523 0.017 CID_154699870 | CID_154699870 | |
| 0.318 | 0.008 | 0.318 | Heat shock protein 90 antagonist | 0.127 0.103 CID_154699870 | ||
| 0.35 | 0.051 | 0.35 | Lipoxygenase inhibitor | |||
| 0.367 | 0.078 | 0.521 | Immunosuppressant | 0.521 0.027 CID_154699870 | CID_154699870 | |
| 0.305 | 0.017 | 0.382 | NOS3 expression enhancer | 0.382 0.009 CID_154699870 | CID_154699870 | |
| 0.326 | 0.04 | 0.409 | Vasodilator | 0.409 0.022 CID_154699870 | CID_154699870 | |
| 0.299 | 0.019 | 0.299 | Tubulin antagonist | 0.116 0.084 CID_154699870 | ||
| 0.282 | 0.003 | 0.282 | Neuraminidase inhibitor | 0.258 0.003 CID_154699870 | ||
| 0.283 | 0.007 | 0.283 | Alpha 2a adrenoreceptor antagonist | |||
| 0.258 | 0.019 | 0.258 | Acetylcholinesterase inhibitor | 0.107 0.094 CID_154699870 | ||
| 0.241 | 0.005 | 0.241 | Papain-like protease (SARS coronavirus) inhibitor | 0.147 0.037 CID_154699870 | ||
| 0.344 | 0.12 | 0.407 | 5 Hydroxytryptamine release inhibitor | 0.407 0.074 CID_154699870 | CID_154699870 | |
| 0.237 | 0.021 | 0.237 | CDC-like kinase 1 inhibitor | |||
| 0.244 | 0.028 | 0.334 | Lipid peroxidase inhibitor | 0.334 0.015 CID_154699870 | CID_154699870 | |
| 0.237 | 0.024 | 0.237 | Cyclooxygenase 1 inhibitor | 0.174 0.046 CID_154699870 | ||
| 0.274 | 0.061 | 0.365 | Antiamyloidogenic | 0.365 0.036 CID_154699870 | CID_154699870 | |
| 0.208 | 0.004 | 0.208 | Neuraminidase (influenza) inhibitor | 0.208 0.004 CID_154699870 | ||
| 0.209 | 0.006 | 0.209 | CDC-like kinase 3 inhibitor | 0.124 0.038 CID_154699870 | ||
| 0.226 | 0.028 | 0.475 | Monophenol monooxygenase inhibitor | 0.475 0.008 CID_154699870 | CID_154699870 | |
| 0.199 | 0.008 | 0.199 | Estrogen receptor alpha antagonist | |||
| 0.248 | 0.058 | 0.248 | Amyloid beta aggregation inhibitor | 0.173 0.093 CID_154699870 | ||
| 0.21 | 0.022 | 0.21 | Cystathionine beta-synthase inhibitor | 0.171 0.033 CID_154699870 | ||
| 0.222 | 0.037 | 0.222 | Cholinergic | |||
| 0.232 | 0.047 | 0.232 | Nitric-oxide synthase stimulant | 0.226 0.053 CID_154699870 | ||
| 0.192 | 0.016 | 0.192 | Antineoplastic alkaloid | 0.077 0.069 CID_154699870 | ||
| 0.2 | 0.025 | 0.228 | DNA intercalator | 0.228 0.019 CID_154699870 | CID_154699870 | |
| 0.221 | 0.052 | 0.221 | P-glycoprotein inhibitor | 0.205 0.06 CID_154699870 | ||
| 0.169 | 0.013 | 0.169 | Electron transport complex I inhibitor | 0.116 0.052 CID_154699870 | ||
| 0.16 | 0.012 | 0.16 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.113 0.029 CID_154699870 | ||
| 0.156 | 0.009 | 0.156 | Alpha tubulin antagonist | |||
| 0.197 | 0.051 | 0.197 | Succinate dehydrogenase inhibitor | |||
| 0.217 | 0.073 | 0.217 | Pyruvate kinase inhibitor | |||
| 0.173 | 0.03 | 0.173 | MAP kinase kinase 4 inhibitor | |||
| 0.262 | 0.119 | 0.262 | Vasodilator, peripheral | 0.219 0.155 CID_154699870 | ||
| 0.153 | 0.014 | 0.153 | Macrophage migration inhibitory factor inhibitor | |||
| 0.142 | 0.005 | 0.142 | Estrogen receptor alpha agonist | |||
| 0.15 | 0.014 | 0.15 | Keratolytic | |||
| 0.154 | 0.019 | 0.154 | DOPA decarboxylase inhibitor | |||
| 0.165 | 0.031 | 0.207 | Microtubule formation inhibitor | 0.207 0.018 CID_154699870 | CID_154699870 | |
| 0.153 | 0.019 | 0.153 | Histidine decarboxylase inhibitor | |||
| 0.215 | 0.083 | 0.356 | Cyclic AMP phosphodiesterase inhibitor | 0.356 0.024 CID_154699870 | CID_154699870 | |
| 0.145 | 0.016 | 0.145 | Dopamine D1 antagonist | |||
| 0.174 | 0.053 | 0.303 | Protein kinase stimulant | 0.303 0.016 CID_154699870 | CID_154699870 | |
| 0.143 | 0.028 | 0.143 | Opioid antagonist | |||
| 0.225 | 0.11 | 0.225 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.112 | 0.006 | 0.112 | Glutamate (mGluR7) antagonist | |||
| 0.152 | 0.046 | 0.371 | Cyclooxygenase 3 inhibitor | 0.371 0.004 CID_154699870 | CID_154699870 | |
| 0.136 | 0.031 | 0.136 | Creatine kinase inhibitor | |||
| 0.144 | 0.039 | 0.144 | Alpha adrenoreceptor antagonist | |||
| 0.108 | 0.005 | 0.108 | Endothelin receptor antagonist | |||
| 0.105 | 0.003 | 0.205 | Sodium/glucose cotransporter 2 inhibitor | 0.205 0.001 CID_154699870 | CID_154699870 | |
| 0.1 | 0.004 | 0.1 | Endothelin B receptor antagonist | 0.017 0.015 CID_154699870 | ||
| 0.116 | 0.021 | 0.116 | Dopamine D3 antagonist | |||
| 0.139 | 0.044 | 0.139 | Alpha 2b adrenoreceptor antagonist | |||
| 0.199 | 0.11 | 0.416 | Tumour necrosis factor alpha release inhibitor | 0.416 0.024 CID_154699870 | CID_154699870 | |
| 0.11 | 0.024 | 0.11 | Alpha adrenoreceptor agonist | |||
| 0.095 | 0.01 | 0.095 | Opioid kappa receptor agonist | 0.038 0.037 CID_154699870 | ||
| 0.177 | 0.095 | 0.177 | Psychostimulant | 0.174 0.097 CID_154699870 | ||
| 0.084 | 0.003 | 0.253 | Sodium/glucose cotransporter inhibitor | 0.253 0.001 CID_154699870 | CID_154699870 | |
| 0.086 | 0.008 | 0.086 | Acetyl-CoA transferase 2 inhibitor | 0.063 0.026 CID_154699870 | ||
| 0.121 | 0.045 | 0.308 | Beta glucuronidase inhibitor | 0.308 0.006 CID_154699870 | CID_154699870 | |
| 0.15 | 0.074 | 0.15 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.11 | 0.034 | 0.11 | Ornithine decarboxylase inhibitor | 0.084 0.063 CID_154699870 | ||
| 0.147 | 0.073 | 0.147 | Cyclooxygenase inhibitor | 0.122 0.097 CID_154699870 | ||
| 0.179 | 0.107 | 0.179 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.077 | 0.005 | 0.077 | Endothelin A receptor antagonist | |||
| 0.094 | 0.024 | 0.094 | Beta tubulin antagonist | |||
| 0.097 | 0.029 | 0.097 | Lipase inhibitor | 0.076 0.048 CID_154699870 | ||
| 0.178 | 0.111 | 0.178 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.076 | 0.01 | 0.076 | Leukotriene C antagonist | |||
| 0.118 | 0.053 | 0.118 | MAO A inhibitor | |||
| 0.075 | 0.011 | 0.075 | Kinesin-like protein 1 inhibitor | |||
| 0.075 | 0.011 | 0.075 | Kinesin antagonist | |||
| 0.142 | 0.078 | 0.142 | Adenylate cyclase stimulant | |||
| 0.064 | 0.005 | 0.064 | Dopamine autoreceptor agonist | |||
| 0.123 | 0.066 | 0.22 | DNA repair enzyme inhibitor | 0.22 0.007 CID_154699870 | CID_154699870 | |
| 0.108 | 0.051 | 0.108 | Antiadrenergic | |||
| 0.105 | 0.051 | 0.105 | Adrenaline antagonist | |||
| 0.085 | 0.031 | 0.085 | Glucagon-like peptide 1 agonist | |||
| 0.094 | 0.041 | 0.094 | mTOR complex 2 inhibitor | |||
| 0.085 | 0.034 | 0.085 | Dopamine agonist | |||
| 0.093 | 0.041 | 0.093 | Dopamine antagonist | |||
| 0.081 | 0.031 | 0.081 | Leukotriene antagonist | 0.071 0.039 CID_154699870 | ||
| 0.092 | 0.043 | 0.092 | Opioid kappa receptor antagonist | |||
| 0.096 | 0.046 | 0.128 | ATPase (Vacuolar H+) inhibitor | 0.128 0.015 CID_154699870 | CID_154699870 | |
| 0.072 | 0.027 | 0.072 | Alpha 1 adrenoreceptor agonist | |||
| 0.081 | 0.037 | 0.081 | Leukotriene synthesis inhibitor | |||
| 0.094 | 0.05 | 0.094 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.049 | 0.006 | 0.049 | Estrogen-related receptor beta antagonist | |||
| 0.082 | 0.039 | 0.082 | Dopamine D2 antagonist | |||
| 0.199 | 0.157 | 0.199 | Prostaglandin dehydrogenase inhibitor | |||
| 0.062 | 0.02 | 0.062 | Topoisomerase II beta inhibitor | 0.049 0.034 CID_154699870 | ||
| 0.054 | 0.013 | 0.054 | Nociceptin (N/OFQ) receptor antagonist | |||
| 0.163 | 0.124 | 0.163 | Dyrk kinase inhibitor | |||
| 0.081 | 0.043 | 0.115 | Histone deacetylase SIRT1 stimulant | 0.115 0.02 CID_154699870 | CID_154699870 | |
| 0.081 | 0.043 | 0.115 | Histone deacetylase stimulant | 0.115 0.02 CID_154699870 | CID_154699870 | |
| 0.161 | 0.123 | 0.161 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.081 | 0.043 | 0.081 | Glutamate decarboxylase inhibitor | |||
| 0.061 | 0.026 | 0.124 | Alpha-mannosidase inhibitor | 0.124 0.004 CID_154699870 | CID_154699870 | |
| 0.133 | 0.099 | 0.133 | Sigma receptor agonist | |||
| 0.067 | 0.033 | 0.067 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.062 0.037 CID_154699870 | ||
| 0.061 | 0.029 | 0.061 | Opioid agonist | |||
| 0.095 | 0.063 | 0.133 | Phosphodiesterase 6D inhibitor | 0.133 0.016 CID_154699870 | CID_154699870 | |
| 0.095 | 0.066 | 0.095 | Butyrylcholinesterase inhibitor | |||
| 0.084 | 0.056 | 0.084 | Acetylcholine M3 receptor agonist | |||
| 0.18 | 0.153 | 0.307 | DNA synthesis inhibitor | 0.307 0.041 CID_154699870 | CID_154699870 | |
| 0.133 | 0.106 | 0.133 | Ca2+-transporting ATPase inhibitor | |||
| 0.053 | 0.028 | 0.061 | Factor III inhibitor | 0.061 0.017 CID_154699870 | CID_154699870 | |
| 0.08 | 0.058 | 0.08 | Phosphodiesterase 11A inhibitor | |||
| 0.08 | 0.058 | 0.08 | Phosphodiesterase XI inhibitor | |||
| 0.08 | 0.061 | 0.08 | Ca(v)3.1 blocker | |||
| 0.137 | 0.121 | 0.378 | Platelet adhesion inhibitor | 0.378 0.014 CID_154699870 | CID_154699870 | |
| 0.024 | 0.011 | 0.024 | Imidazoline I1 receptor antagonist | |||
| 0.06 | 0.047 | 0.06 | Protease activated receptor antagonist | |||
| 0.045 | 0.032 | 0.117 | Mannosidase inhibitor | 0.117 0.005 CID_154699870 | CID_154699870 | |
| 0.09 | 0.078 | 0.09 | Urease inhibitor | |||
| 0.058 | 0.046 | 0.058 | Adrenaline uptake inhibitor | |||
| 0.075 | 0.064 | 0.075 | Carbonic anhydrase VI inhibitor | |||
| 0.07 | 0.06 | 0.103 | Na+ K+ transporting ATPase inhibitor | 0.103 0.029 CID_154699870 | CID_154699870 | |
| 0.119 | 0.11 | 0.119 | Acetylcholine M1 receptor antagonist | |||
| 0.039 | 0.03 | 0.039 | Dopamine D5 agonist | |||
| 0.076 | 0.067 | 0.076 | Calcium antagonist | |||
| 0.072 | 0.063 | 0.197 | Antineoplastic antibiotic | 0.197 0.022 CID_154699870 | CID_154699870 | |
| 0.089 | 0.081 | 0.089 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.057 | 0.049 | 0.057 | Ryanodine receptor antagonist | |||
| 0.013 | 0.005 | 0.013 | Imidazoline I2 receptor antagonist | |||
| 0.053 | 0.046 | 0.053 | Aromatase inhibitor | |||
| 0.055 | 0.05 | 0.055 | Heat shock protein 90 beta antagonist | |||
| 0.022 | 0.017 | 0.027 | Dopamine D1 agonist | 0.027 0.01 CID_154699870 | CID_154699870 | |
| 0.056 | 0.052 | 0.056 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.067 | 0.065 | 0.067 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.047 | 0.052 | 0.059 | Leukotriene B4 antagonist | 0.059 0.028 CID_154699870 | CID_154699870 | |
| 0.038 | 0.055 | 0.069 | Aldose reductase inhibitor | 0.069 0.027 CID_154699870 | CID_154699870 | |
| 0.079 | 0.096 | 0.131 | Xanthine oxidase inhibitor | 0.131 0.042 CID_154699870 | CID_154699870 | |
| 0.088 | 0.107 | 0.105 | Beta amyloid protein antagonist | 0.105 0.084 CID_154699870 | CID_154699870 | |
| 0.134 | 0.155 | 0.281 | Hypolipemic | 0.281 0.055 CID_154699870 | CID_154699870 | |
| 0.084 | 0.111 | 0.179 | Alkylator | 0.179 0.033 CID_154699870 | CID_154699870 | |
| 0.074 | 0.106 | 0.225 | Expectorant | 0.225 0.016 CID_154699870 | CID_154699870 | |
| 0.119 | 0.174 | 0.225 | ATPase inhibitor | 0.225 0.022 CID_154699870 | CID_154699870 | |
| 0.121 | 0.184 | 0.305 | Platelet antagonist | 0.305 0.051 CID_154699870 | CID_154699870 | |
| 0.031 | 0.096 | 0.043 | Glucose-6-phosphate isomerase inhibitor | 0.043 0.042 CID_154699870 | CID_154699870 | |
| 0.105 | 0.177 | 0.171 | Interferon gamma antagonist | 0.171 0.056 CID_154699870 | CID_154699870 | |
| 0.008 | 0.082 | 0.032 | Squalene synthetase inhibitor | 0.032 0.022 CID_154699870 | CID_154699870 | |
| 0.145 | 0.231 | 0.325 | Cholesterol antagonist | 0.325 0.076 CID_154699870 | CID_154699870 | |
| 0.029 | 0.126 | 0.067 | Phosphofructokinase-1 inhibitor | 0.067 0.05 CID_154699870 | CID_154699870 | |
| 0.137 | 0.235 | 0.351 | Peptidyltransferase inhibitor | 0.351 0.012 CID_154699870 | CID_154699870 | |
| 0.024 | 0.123 | 0.041 | Microtubule stabilization | 0.041 0.04 CID_154699870 | CID_154699870 | |
| 0.1 | 0.199 | 0.181 | Interleukin 6 antagonist | 0.181 0.054 CID_154699870 | CID_154699870 | |
| 0.042 | 0.141 | 0.06 | Lipocortins synthesis agonist | 0.06 0.036 CID_154699870 | CID_154699870 | |
| 0.066 | 0.166 | 0.146 | Toll-Like receptor 4 antagonist | 0.146 0.023 CID_154699870 | CID_154699870 | |
| 0.057 | 0.158 | 0.091 | NADH dehydrogenase inhibitor | 0.091 0.055 CID_154699870 | CID_154699870 | |
| 0.055 | 0.159 | 0.111 | UDP-glucose 4-epimerase inhibitor | 0.111 0.05 CID_154699870 | CID_154699870 | |
| 0.058 | 0.163 | 0.126 | Transcription factor NF kappa B stimulant | 0.126 0.023 CID_154699870 | CID_154699870 | |
| 0.185 | 0.298 | 0.701 | Cyclophilin D inhibitor | 0.701 0.014 CID_154699870 | CID_154699870 | |
| 0.011 | 0.124 | 0.037 | Protein 30S ribosomal subunit inhibitor | 0.037 0.011 CID_154699870 | CID_154699870 | |
| 0.061 | 0.181 | 0.099 | Multidrug resistance-associated protein 1 inhibitor | 0.099 0.08 CID_154699870 | CID_154699870 | |
| 0.1 | 0.22 | 0.394 | Immunostimulant | 0.394 0.051 CID_154699870 | CID_154699870 | |
| 0.02 | 0.151 | 0.066 | Antibiotic Aminoglycoside-like | 0.066 0.007 CID_154699870 | CID_154699870 | |
| 0.025 | 0.162 | 0.063 | Nitric oxide donor | 0.063 0.044 CID_154699870 | CID_154699870 | |
| 0.039 | 0.181 | 0.072 | Glycine receptor antagonist | 0.072 0.071 CID_154699870 | CID_154699870 | |
| 0.059 | 0.202 | 0.105 | Alpha-N-acetylglucosaminidase inhibitor | 0.105 0.094 CID_154699870 | CID_154699870 | |
| 0.072 | 0.227 | 0.207 | Cell wall synthesis inhibitor | 0.207 0.027 CID_154699870 | CID_154699870 | |
| 0.018 | 0.184 | 0.043 | Neuraminidase (Influenza A) inhibitor | 0.043 0.036 CID_154699870 | CID_154699870 | |
| 0.024 | 0.208 | 0.068 | Glucose-6-phosphate translocase inhibitor | 0.068 0.017 CID_154699870 | CID_154699870 | |
| 0.119 | 0.305 | 0.505 | Antithrombotic | 0.505 0.028 CID_154699870 | CID_154699870 | |
| 0.046 | 0.234 | 0.151 | AMP-activated protein kinase stimulant | 0.151 0.027 CID_154699870 | CID_154699870 | |
| 0.023 | 0.224 | 0.079 | Heparanase inhibitor | 0.079 0.007 CID_154699870 | CID_154699870 | |
| 0.017 | 0.218 | 0.086 | Protein 50S ribosomal subunit inhibitor | 0.086 0.017 CID_154699870 | CID_154699870 | |
| 0.036 | 0.27 | 0.082 | Uric acid excretion stimulant | 0.082 0.079 CID_154699870 | CID_154699870 | |
| 0.058 | 0.375 | 0.152 | Non-steroidal antiinflammatory agent | 0.152 0.113 CID_154699870 | CID_154699870 | |
| 0.036 | 0.39 | 0.52 | Angiogenesis stimulant | 0.52 0.011 CID_154699870 | CID_154699870 | |
| 0.047 | 0.422 | 0.196 | Hemostatic | 0.196 0.034 CID_154699870 | CID_154699870 | |
| 0.044 | 0.443 | 0.18 | Insulin secretagoues | 0.18 0.048 CID_154699870 | CID_154699870 | |
| 0.076 | 0.62 | 0.332 | Interleukin 2 agonist | 0.332 0.054 CID_154699870 | CID_154699870 | |
| 0.005 | 0.589 | 0.288 | Selectin antagonist | 0.288 0.006 CID_154699870 | CID_154699870 | |
| 0.013 | 0.673 | 0.196 | Thrombolytic | 0.196 0.054 CID_154699870 | CID_154699870 | |
| 0.008 | 0.706 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.023 CID_154699870 | CID_154699870 | |
| 0.013 | 0.717 | 0.141 | Cell adhesion inhibitor | 0.141 0.052 CID_154699870 | CID_154699870 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |